Australian Immunisation Handbook: Vaccination for special risk groups updated
这 澳大利亚免疫手册 guidance about the vaccination of special risk groups was recently updated.
As of 2 May 2025, a significantly updated chapter on immunocompromise provides clear definitions and categorises the level of immunocompromise across various types of conditions. Subsections in this chapter include:
- Introduction and general principles
- Inborn errors of immunity (IEI), including primary immunodeficiency
- Secondary (acquired) immunodeficiency due to medical conditions
- Secondary (acquired) immunodeficiency due to medical therapies
- People with asplenia and hyposplenia
- Infants exposed to immunosuppressive therapy in utero or through breastmilk
- Close contacts of people who are immunocompromised
- Travellers who are immunocompromised.
这 Vaccination for women who are planning pregnancy, pregnant or breastfeeding Vaccination for international travellers chapters were also updated.
MVEC：免疫抑制和疫苗
MVEC: Immunosuppression in pregnancy and infant vaccine recommendations
墨尔本疫苗教育中心（MVEC）：孕妇疫苗接种
AAP FactCheck debunks more circulating vaccine misinformation
AAP FactCheck has recently assessed online claims regarding the COVID-19 and MMR vaccines.
According to the FactCheck team, a Facebook post claiming that myocarditis from COVID-19 vaccines will lead to millions of deaths is based on a misrepresentation of the Cleaveland Clinic’s information published about viral myocarditis.
Read AAP FactCheck’s full article for a detailed breakdown of why the claim is false.
Go to MVEC：COVID-19 for information about COVID-19 disease, epidemiology and vaccination.
AAP FactCheck has also deemed that claims a baby in the US developed measles from the MMR vaccine are misleading. Health authorities say there is no evidence that the vaccine caused measles in this case.
AAP FactCheck: Misinformation spreads amid measles outbreak
MVEC：麻疹
Infectious IDeas: A Lifelong Champion of Vaccine Safety—Kathryn M. Edwards, MD (podcast)
Dr Kathryn Edwards is a renowned expert in childhood respiratory diseases, and vaccine safety and efficacy in the United States.
In this podcast episode, Dr Edwards shares her journey to becoming a trailblazer in paediatric infectious disease prevention. Dr Edwards discusses the importance of vaccine safety and adverse event monitoring.
Infectious IDeas: A Lifelong Champion of Vaccine Safety—Kathryn M. Edwards, MD (podcast)
Save the date: CVU mini on immunisation and special risk groups
MVEC is excited to announce our upcoming webinar on immunisation and special risk groups, the latest in our CVU mini series.
Save the date – registrations opening soon!
日期： Wednesday 4 June 2025
地点： online
注册费用： free event
Our CVU mini event page will be updated with more details.
TGA: Arexvy approved for use in adults aged 50 to 59 with RSV risk
这 Therapeutics Goods Administration (TGA) has extended the approval of the RSV vaccine Arexvy to include adults aged 50 to 59 years who are at increased risk for RSV disease.
Arexvy is also approved for use in all adults aged 60 years and older.
For more information on RSV disease and vaccination, see MVEC’s updated RSV immunisation reference.
Chief Medical Officer’s letter regarding measles vaccination
On 15 April 2025 the Australian Department of Health and Aged Care Chief Medical Officer (CMO) Prof Anthony Lawler shared a message regarding the recent increase in confirmed cases of measles across Australia.
The CMO emphasised the critical role of vaccination in preventing measles. The full letter can be read here.
Following on from this letter, the CMO released an additional message to highlight state- and territory-funded measles programs that offer free protection to certain groups, on top of the NIP-funded groups; and the importance of checking patients’ vaccine history.
Visit your local health department’s immunisation website for more information.
Updated immunisation reference page: Translated 2025 influenza page
Translated versions of MVEC’s newly updated 2025 influenza reference page are now available. Access the reference in Vietnamese, Hindi and Simplified Chinese.
MVEC’s influenza reference page details recommendations for flu vaccination in 2025, including:
- influenza strains included in this year’s vaccines
- brands available by age and funding
- commonly asked questions.
Switch between languages using the dropdown box at the beginning of the page.
MVEC：流感
Australian Immunisation Handbook: Influenza chapter updated
这 Australian Immunisation Handbook chapter on influenza was updated on 7 April 2025 to reflect 2025 influenza vaccine information.
Immunisation Coalition: 9th Annual Immunisation Forum (AIF)
这 Immunisation Coalition will host the 9日 Annual Immunisation Forum (AIF) hybrid event on Friday 13 June 2025 in Adelaide, immediately following CDIC 2025.
The meeting is tailored to GPs, practice nurses, specialists, pharmacists and other immunisation specialists.
For more information, including the program, and to register, visit the 免疫联盟的活动页面.
Immunisation Coalition: RSV Dinner Meeting
这 Immunisation Coalition will be hosting an RSV Dinner Meeting at which leading experts will discuss:
- early learnings from the maternal vaccination and infant immunisation RSV programs
- how to increase vaccination rates
- where the focus should be for adults 60 years and over.
Location: Adelaide Convention Centre, North Terrace, Adelaide OR online
Date: Tuesday 10 June 2025
Learn more and register on the 免疫联盟的活动页面.